Picture of Biohit Oyj logo

BIOBV — Biohit Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Biohit: GastroPanel Validated As Predictor Of Gastric Cancer Risk In Multicenter Study

April 9 (Reuters) - Biohit Oyj  BIOBV.HE :
    * BIOHIT GASTROPANEL® BIOMARKERS VALIDATED AS POWERFUL
PREDICTORS
OF GASTRIC CANCER RISK IN A MULTICENTER STUDY

Source text for Eikon:  ID:nGNE33CTNt 
Further company coverage:  BIOBV.HE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Biohit Oyj

See all news